Pyxis Oncology, Inc. (PYXS)
NASDAQ·Healthcare·Biotechnology
$3.11
+2.30%
Mkt Cap $181.83M
Analyst Ratings
Buy
3
Hold
0
Sell
0
Price Target (8 analysts)
$5.50
Range $5.00 – $6.00
Implied Upside
+76.8%
Consensus $5.50 vs current $3.11
NASDAQ·Healthcare·Biotechnology
$3.11
+2.30%
Mkt Cap $181.83M
Buy
3
Hold
0
Sell
0
Price Target (8 analysts)
$5.50
Range $5.00 – $6.00
+76.8%
Consensus $5.50 vs current $3.11